Clinical Trial Update: A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial update for CSL112 in adults with moderate renal impairment and acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Myocardial Infarction

Drugs mentioned

• CSL112

Snippet

Sponsor: CSL Behring | Conditions: Acute Myocardial Infarction, Moderate Renal Impairment | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11